Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This is an exploratory phase 1b/2, global, multicenter, single-arm, 2-part (phase 1b and 2)
study of conatumumab in combination with panitumumab in patients with Metastatic Colorectal
Cancer.